Cerus (CERS) Gains from Investment Securities (2010 - 2026)
Cerus' (CERS) quarterly Gains from Investment Securities came in at -$1000.0 in Q1 2026, down 100.01% year-on-year from $10.8 million in Q1 2025, and down 109.09% quarter-over-quarter from $11000.0 in Q4 2025.
Cerus (CERS) Gains from Investment Securities (2010 - 2026) Analysis & Trends
Cerus has disclosed Gains from Investment Securities across 17 years of filings, most recently posting -$1000.0 for Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at -$1000.0, down 100.01% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5000.0 (down 100.05% YoY), and the FY2025 annual result was $10.0 million, down 18.46% from the prior year.
- Gains from Investment Securities came in at -$1000.0 for Q1 2026 at Cerus, down from $11000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $14.5 million in Q3 2023 to a low of -$15000.0 in Q4 2023.
- The 5-year median for Gains from Investment Securities is $5.7 million (2022), against an average of $6.6 million.
- Across the five-year window, Gains from Investment Securities sank 100.77% in 2023 and soared 433933.33% in 2024, its largest moves.
- Cerus' Gains from Investment Securities stood at $1.9 million in 2022, then tumbled by 100.77% to -$15000.0 in 2023, then surged by 14720.0% to $2.2 million in 2024, then plunged by 99.5% to $11000.0 in 2025, then plunged by 109.09% to -$1000.0 in 2026.
- The last three Gains from Investment Securities figures came in at -$1000.0 (Q1 2026), $11000.0 (Q4 2025), and $10.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Cerus | 496.03 Mn | 416.34 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 10.03 Mn |
| Sep 30, 2025 | 10.03 Mn |
| Jun 30, 2025 | 10.83 Mn |
| Jun 30, 2025 | 10.83 Mn |
| Mar 31, 2025 | 10.80 Mn |
| Mar 31, 2025 | 10.80 Mn |
| Sep 30, 2024 | 2.19 Mn |
| Sep 30, 2024 | 2.19 Mn |
| Jun 30, 2024 | 12.79 Mn |
| Jun 30, 2024 | 12.79 Mn |
| Mar 31, 2024 | 13.02 Mn |
| Mar 31, 2024 | 13.02 Mn |
| Dec 31, 2023 | -15,000.00 |
| Dec 31, 2023 | -15,000.00 |
| Sep 30, 2023 | 14.53 Mn |
| Sep 30, 2023 | 14.53 Mn |